http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012520060-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
filingDate 2010-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2012520060-A
titleOfInvention Cell-specific effective molecules based on siRNA, application kits for the production of the molecules and use of the molecules
abstract siRNA-based cell-specific effective molecules, application kits for the production of the molecules and use of the molecules. 2.1. An object of the present invention is to form a bond between siRNA and one or more peptides, wherein the siRNA is activated after peptide separation and significantly reduces the biological efficacy of the activated siRNA in the cell. And / or leave no peptide. 2.2. According to the present invention, peptide (3) is coupled to siRNA (2) via a special amino Cn linker, such as amino C6 linker (1). Despite the amino Cn linker remaining in the siRNA and in some cases also leaving peptide residues, it does not reduce or significantly inhibit the biological efficacy of the siRNA. 2.3. The molecule is used, for example, to influence gene expression in an organ or cell, preferably having a disease or infection, or to reduce the expression of a target gene in a cell mixture. [Selection] Figure 1
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015536146-A
priorityDate 2009-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008098569-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114555
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Z2E3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426340625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2081
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID78943
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID493961
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11437275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49662
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12363
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO75460
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403724
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ76MJ5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9EQY0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID830507
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID856478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26918
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5E9C1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42358
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID112442685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44450050
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID338039
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID553551

Total number of triples: 45.